385 results
Responsible body
PRAC Remove PRAC filter
-
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5-8 March 2018
European Medicines Agency, London, UK, from 05/03/2018 to 08/03/2018, Last updated: 05/03/2018 -
List item
Press release: EMA urgently reviewing multiple sclerosis medicine Zinbryta following cases of inflammatory brain disorders
PRAC, Last updated: 02/03/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 August 2020
European Medicines Agency, Amsterdam, the Netherlands, from 03/08/2020 to 06/08/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 May 2020
European Medicines Agency, Amsterdam, the Netherlands, from 11/05/2020 to 14/05/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 June 2020
European Medicines Agency, Amsterdam, the Netherlands, from 08/06/2020 to 11/06/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 10-13 February 2020
European Medicines Agency, Amsterdam, the Netherlands, from 10/02/2020 to 13/02/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 January 2021
Virtual meeting, from 11/01/2021 to 14/01/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 March 2021
European Medicines Agency, Amsterdam, the Netherlands, from 08/03/2021 to 11/03/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 5 August 2021
European Medicines Agency, Amsterdam, the Netherlands, 05/08/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 31 August-3 September 2020
Virtual meeting, from 31/08/2020 to 03/09/2020, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 30 August-2 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 30/08/2021 to 02/09/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 September 2021
European Medicines Agency, Amsterdam, the Netherlands, from 27/09/2021 to 30/09/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 3-6 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 03/05/2021 to 06/05/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 6-9 April 2021
European Medicines Agency, Amsterdam, the Netherlands, from 06/04/2021 to 09/04/2021, Last updated: 27/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 13-16 May 2019
European Medicines Agency, Amsterdam, the Netherlands, from 13/05/2019 to 16/05/2019, Last updated: 26/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 11-14 February 2019
European Medicines Agency, from 11/02/2019 to 14/02/2019, Last updated: 26/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 2-5 September 2019
European Medicines Agency, Amsterdam, the Netherlands, from 02/09/2019 to 05/09/2019, Last updated: 26/02/2018 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 8-11 April 2019
European Medicines Agency, Amsterdam, the Netherlands, from 08/04/2019 to 11/04/2019, Last updated: 26/02/2018 -
List item
Press release: PRAC recommends new measures to avoid valproate exposure in pregnancy
PRAC, Last updated: 09/02/2018 -
List item
Press release: Women taking Esmya for uterine fibroids to have regular liver tests while EMA review is ongoing
PRAC, Last updated: 09/02/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 5-8 February 2018
PRAC, Last updated: 09/02/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 8-11 January 2018
PRAC, Last updated: 12/01/2018 -
List item
Press release: PRAC recommends suspending hydroxyethyl-starch solutions for infusion from the market
PRAC, Last updated: 12/01/2018 -
List item
News: Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 27-30 November 2017
PRAC, Last updated: 01/12/2017 -
List item
Pharmacovigilance Risk Assessment Committee (PRAC): 27-30 November 2017
European Medicines Agency, London, UK, from 27/11/2017 to 30/11/2017, Last updated: 27/11/2017